1. Israel Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Pulsenmore Ltd.

Pulsenmore Ltd.

PULS.TA
Pulsenmore Ltd.IL flagTel Aviv Stock Exchange
1,846.00
ILA
-15.00
- -
120.04MMarket Cap
Pulsenmore Ltd.
PULS.TA
(Tel Aviv Stock Exchange)

Recent

price

1,846.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

Invalid Date
Invalid Date
Invalid Date
Invalid Date
Invalid Date
Invalid Date
FRC
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
6
6
5
6
6
6
Basic Weighted Avg Shares
- -
- -
2
11
6
10
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
1
1
2
3
Depreciation Expense
-5
-14
-26
-22
-59
-37
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
3
2
1
LT Debt
4
3
154
188
132
97
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
1,031.75%
-26.73%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
78.11%
-37.28%
Sales/Revenue/Turnover
- -
- -
56.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available
Similar Companies
FUJIFILM Holdings Corporation (FJI.F)
Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
Bioptik Technology Incorporation (4161.TWO)
Perseon Corporation (PRSN)
E-Qure Corp. (EQUR)
Shanghai Kinetic Medical Co., Ltd (300326.SZ)
Business
Pulsenmore Ltd. develops and commercializes innovative self-scan ultrasound systems for remote clinical assessment, primarily focused on transforming prenatal care. The company's core offering, the Pulsenmore ES, integrates a portable ultrasound device that securely docks with a patient's personal smartphone, utilizing a dedicated mobile application to guide users through diagnostic imaging procedures for fetal monitoring. This system then facilitates the secure transmission and display of these ultrasound images via a cloud-based software platform, enabling healthcare professionals to remotely review and interpret the scans. Pulsenmore aims to expand access to high-quality maternal health services, particularly in underserved regions, by enabling at-home monitoring under physician supervision. The company has received significant regulatory milestones, including FDA De Novo marketing authorization in November 2025 for its home-use prenatal ultrasound platform in the United States, paving the way for a phased U.S. launch in early 2026. Pulsenmore also offers solutions for remote follicular monitoring in IVF treatments and is actively exploring additional medical applications for its home ultrasound technology. The company was established in 2014 and maintains its base of operations in Omer, Israel.